Navigation Links
WuXi PharmaTech Announces Second Quarter 2007 Results
Date:9/5/2007

tements, whether as a

result of new information, future events or otherwise, after the date of this press release. Such information speaks only as of the date of this release.

WUXI PHARMATECH (CAYMAN) INC.

CONSOLIDATED BALANCE SHEETS

(in thousands of US Dollars, except share data and par value data)

June 30, December 31,

2007 2006

Assets: (Unaudited)

Current assets:

Cash and cash equivalents 48,491 9,683

Restricted cash 4,426 2,067

Accounts receivables, net 14,865 12,589

Inventories 14,721 9,617

Prepaid expenses and other current assets 5,725 2,696

Total current assets 88,228 36,652

Non-current assets:

Property, plant and equipment, net 56,588 42,776

Intangible assets, net 787 628

Land use rights, net 5,009 4,643

Other non-current assets 1,274 992

Total non-current assets 63,658 49,039

Total assets 151,886 85,691

Liabilities, mezzanine equity and

shareholders' deficit

Current liabilities:

Short-term bank borrowings, current 1,970 9,604

Accounts payables 7,486 9,259

Accrued expenses 9,223 5,012

Deferred revenue 13,408
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... (PRWEB) May 17, 2013 Oven Industries ... capabilities. The 5R6-900 temperature controller has many user-friendly benefits. ... plugged into the wall as a self-contained temperature ... This distinctive detail makes the device unique, as well ... controller can also be used universally, which allows the ...
(Date:5/17/2013)... release is available in German . ... well: with the naked eye, you can see which branch ... the blur of branches through the telephoto lens for high-magnification ... researchers who are looking to study proteins, the active biomolecules ... Zurich,s Institute for Molecular Systems Biology, and her colleagues have ...
(Date:5/17/2013)... 2013 The new Public-Private Partnership (PPP) ... the association’s recent annual meeting drew praise from community ... Kroes, who called the action “a huge step forward ... to European innovation.” , The Board of Stakeholders voted ... Photonics PPP at its 29 April meeting in Brussels, ...
(Date:5/17/2013)... , May 17, 2013 ... the most innovative thought leaders of the medical ... Manufacturing East conference and expo, from June 18-20 ...      (Photo: http://photos.prnewswire.com/prnh/20130517/613829 ) , ... to deliver industry professionals practical presentations and implementable ...
Breaking Biology Technology:New Temperature Control Products Announced by Oven Industries Inc. 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2
... the world over are striving to develop organic solar cells ... that could be widely used to generate electricity. But ... form the proper structure at the nanoscale (tinier than 2-millionths ... to electricity. The goal is to develop cells made from ...
... , , , , ... Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on ... 30, 2009, and provided a corporate update. , , ... we reported promising Phase 2 picoplatin data from our colorectal and ...
... , LYNBROOK, N.Y., Aug. 4 ... biopharmaceutical company developing first in class collagenase-based products, announced today ... audio webcast at 4:30 p.m. ET on Wednesday, August 12, ... corporate highlights. , , To participate ...
Cached Biology Technology:Plastics that convert light to electricity could have a big impact 2Plastics that convert light to electricity could have a big impact 3Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 8BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009 2
(Date:5/16/2013)... entirety of an individual,s DNA is examined to look ... health problems is a massively useful technology for diagnosing ... problems if used incorrectly, say new recommendations from the ... today (16 May 2013) in the European Journal ... genome and on exome* sequencing and analysis are now ...
(Date:5/16/2013)... 16, 2013 Reportlinker.com announces that ... in its catalogue: Global ... http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... practises such as photographs, passwords and PIN ... technologies in last few years. Security threats ...
(Date:5/15/2013)... to date to examine the efficacy of PARP inhibitor ... breast and ovarian cancer, the oral drug olaparib was ... cancers. Results of the study, led by researchers from ... Pennsylvania and Sheba Medical Center in Tel Hashomer, Israel, ... Oncology,s annual meeting in Chicago in early June (Abstract ...
Breaking Biology News(10 mins):European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2
... 2012) The National Eye Institute has awarded researchers ... Mass. Eye and Ear, a five year-grant totaling more ... allergies (NEI Grant Number 1R01EY021798-01A1). Daniel R. Saban, ... formally entitled "Cellular and Molecular Mechanisms that Contributed to ...
... Visualize this ASU classroom: a dark green Panamanian tropical jungle. ... moves overhead so slowly that a leaf nearby spins unscathed ... poop, parrot feathers and leaf matter rain down, startling brilliant ... floor alongside six teams of students from ASU,s Herberger ...
... Research into biofuel crops such as switchgrass and ... crops and convert them into fuels. But many steps lead ... or hinder the growth of this new industry. A new ... this transition, researchers say. The model can run millions of ...
Cached Biology News:Tropical classroom inspires exhibit, Smithsonian field station design 2Tropical classroom inspires exhibit, Smithsonian field station design 3From field to biorefinery: Computer model optimizes biofuel operations 2From field to biorefinery: Computer model optimizes biofuel operations 3
...
Rabbit polyclonal to ZNF261 ( Abpromise for all tested applications). entrezGeneID: 9203 SwissProtID: Q14202...
...
sTNF-receptor I Polyclonal Antibody 100 ug affinity purified rabbit anti-human sTNF-receptor I polyclonal antibody. Performs well in WB/Elisa/Neutralization....
Biology Products: